Assessing response in bone metastases in prostate cancer with diffusion weighted MRI

European Radiology

Volumn 21, Issue 10, 2011, Pages 2169-2177

  Messiou, C ^a   Collins, D J ^a   Giles, S ^a   De Bono, J S ^b   Bianchini, D ^b   De Souza, N M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Bone; Diffusion magnetic resonance imaging; Neoplasm metastasis; Prostate; Therapy

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIFFUSION WEIGHTED IMAGING; DISEASE MARKER; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOLOGICAL PARAMETERS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE NEOPLASMS; CARCINOMA; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 80053915027     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2173-8     Document Type: Article

References (16)

1. A Clamp S Danson H Nguyen D Cole M Clemons 2004 Assessment of therapeutic response in patients with metastatic bone disease Lancet Oncol 5 607 616 15465464 10.1016/S1470-2045(04)01596-7
2. HI Scher 2003 Prostate carcinoma: defining therapeutic objectives and improving overall outcomes Cancer Suppl 97 758 771
3. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228-247
4. T Takahara Y Imai T Yamashita S Yasuda S Nasu M Van Cauteren 2004 Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display Radiat Med 22 275 282 15468951
5. TG Reese O Heid RM Weisskoff VJ Wedeen 2003 Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo Magn Reson Med 49 177 182 12509835 10.1002/mrm.10308 1:STN:280:DC%2BD3s%2FgtlGmsA%3D%3D
6. Messiou CM, Collins DJ, Morgan VA, deSouza NM (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol. doi: 10.1007/s00330-011-2116-4
7. GJ Bubley M Carducci W Dahut N Dawson D Daliani M Eisenberger, et al. 1999 Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate Specific Antigen Working Group J Clin Oncol 17 3461 3467 10550143 1:STN:280: DC%2BD3c%2FhvValsg%3D%3D
8. KC Lee DA Bradley M Hussain CR Meyer TL Chenevert JA Jacobson, et al. 2007 A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone Neoplasia 9 1003 1011 18084607 10.1593/neo.07954
9. D Ballon R Watts JP Dyke E Lis MJ Morris HI Scher, et al. 2004 Imaging therapeutic response in human bone marrow using rapid whole-body MRI Magn Reson Med 52 1234 1238 15562475 10.1002/mrm.20291
10. S Rozel CJ Galbán K Nicolay KC Lee S Sud C Neeley, et al. 2009 Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model J Cell Biochem 107 58 64 19259948 10.1002/jcb.22056 1:CAS:528:DC%2BD1MXlsFymtLk%3D
11. KC Lee S Sud CR Meyer BA Moffat TL Chenevert A Rehemtulla, et al. 2007 An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone Cancer Res 67 3524 3528 17440058 10.1158/0008-5472.CAN- 06-4236 1:CAS:528:DC%2BD2sXkt1Kjtbg%3D
12. C Reischauer JM Froehlich DM Koh N Graf C Padevit H John CA Binkert P Boesiger A Gutzeit 2010 Bone metastases from prostate cancer: Assessing treatment response by using diffusion weighted imaging and functional diffusion maps - initial observations Radiology 257 523 531 20829534 10.1148/radiol. 10092469
13. SH Park SJ Kim BC Park KJ Suh JY Lee CW Park IH Shin IH Jeon 2010 Three-dimensional osseous micro-architecture of the distal humerus: implications for internal fixation of osteoporotic fracture J Shoulder Elbow Surg 19 244 250 19959376 10.1016/j.jse.2009.08.005
14. A Mundinger B Wiesmeier E Dinkel A Helwig A Beck J Schulte Moenting 1993 Quantitative image analysis of vertebral body architecture-improved diagnosis in osteoporosis based on high-resolution computed tomography Br J Radiol 66 209 213 8472113 10.1259/0007-1285-66-783-209 1:STN:280:DyaK3s3jtVelsg%3D%3D
15. MJ Morris T Akhurst I Osman R Nunez H Macapinlac K Siedlecki D Verbel L Schwartz SM Larson HI Scher 2002 Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer Urology 59 913 918 12031380 10.1016/S0090-4295(02)01509-1
16. MJ Morris T Akhurst SM Larson M Ditullio E Chu K Siedlecki D Verbel G Heller WK Kelly S Slovin L Schwartz HI Scher 2005 Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy Clin Cancer Res 11 3210 3216 15867215 10.1158/1078-0432.CCR-04-2034 1:CAS:528:DC%2BD2MXjslOqsb4%3D